Market Overview:
The global coartem market is expected to register a CAGR of xx% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of malaria, rising demand for coartem in developing countries, and growing awareness about the benefits of early diagnosis and treatment. However, factors such as high cost of treatment and lack of skilled professionals are likely to hamper the growth of this market during the forecast period. Based on type, the global coartem market is segmented into artemether and lumefantrine. The artemether segment is expected to account for a larger share in terms of revenue than lumefantrine during the forecast period. This can be attributed to its higher efficacy against malaria parasites as compared to lumefantrine. Based on application, the global coartem market is segmented into hospital pharmacy, retail pharmacy, online pharmacy.
Product Definition:
Coartem is a fixed-dose artemisinin-based combination therapy used to treat malaria. It is a combination of artemether and lumefantrine. Coartem is important because it can effectively treat malaria, especially in areas where chloroquine-resistant strains are common.
Artemether:
Artemether is an insecticide used to control the growth of malaria parasites in humans and other animals. It works by blocking a parasite enzyme that is needed for cell division. Artemether/lumefantrine combination is used to treat both human and animal malaria infections.
Coartemic or artemic acid are the first line treatment for P.
Lumefantrine:
Lumefantrine is a semi-synthetic derivative of artemisinine, which is an insecticide used to control insects in various crops. It works by blocking the sodium channels in the insect’s nervous system. The crop protection industry has witnessed significant growth over the past few years owing to increasing awareness among farmers about pest management and sustainable agricultural practices.
Application Insights:
The global market is segmented by application into hospital pharmacy, retail pharmacy, and online pharmacy. The online pharmacies dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as increasing internet accessibility and rising disposable income among the population globally. Moreover, government initiatives encouraging Online Pharmacy Services (OPS) are expected to further fuel the growth over the forecast period. For instance, according to a survey conducted by eHealth Canada in 2018, around 94% of Canadian adults aged 18 years or above have used some form of OPD at a pharmacist's office or clinic setting during their lifetime while 80% have done so within the last year.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable healthcare policies, increasing COVID-19 positive cases, and high adoption of advanced therapeutics. The region is expected to continue its dominance over the forecast period due to factors such as well-established healthcare infrastructure and rising prevalence of chronic diseases. Moreover, increasing number of hospital pharmacies will further drive the regional market.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period owing to improving economic conditions in emerging countries such as India & China and increased focus on quality medical care by government authorities. These factors are expected to boost demand for ARTEM ether/lumefantrine combination tablets in this region over next eight years.
Growth Factors:
- Increasing prevalence of malaria: The increasing prevalence of malaria is one of the key growth drivers for the Coartem market. According to the World Health Organization (WHO), there were an estimated 214 million cases of malaria and 438,000 deaths due to malaria in 2015. This number is projected to increase to around 216 million cases and 445,000 deaths by 2020. This growing incidence of malaria is expected to drive demand for Coartem products globally.
- Rising awareness about effective treatment options: There is a growing awareness among people about the effective treatment options available for malaria, including Coartem products. This has led to an increase in demand for these products in recent years.
- Availability of generic versions: The availability of generic versions of Coartem has helped make these drugs more affordable and accessible to a larger population base worldwide. As a result, this drug class is witnessing strong growth rates across regions where it is available generically at affordable prices..
Scope Of The Report
Report Attributes
Report Details
Report Title
Coartem(Artemether/Lumefantrine) Market Research Report
By Type
Artemether, Lumefantrine
By Application
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Companies
Novartis, Sanofi-Aventis, KPC Pharmaceuticals, Inc, Guangxi Xiancaotang Pharmaceutical Co., LTD, Guilin Pharmaceutical Co., Ltd, Kerui Nanhai Pharmaceutical, Kunming Pharmaceutical, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Coartem(Artemether/Lumefantrine) Market Report Segments:
The global Coartem(Artemether/Lumefantrine) market is segmented on the basis of:
Types
Artemether, Lumefantrine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Sanofi-Aventis
- KPC Pharmaceuticals, Inc
- Guangxi Xiancaotang Pharmaceutical Co., LTD
- Guilin Pharmaceutical Co., Ltd
- Kerui Nanhai Pharmaceutical
- Kunming Pharmaceutical
- Novartis
Highlights of The Coartem(Artemether/Lumefantrine) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Artemether
- Lumefantrine
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Coartem(Artemether/Lumefantrine) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Coartem is a combination of artemether and lumefantrine. It is used to treat malaria.
Some of the key players operating in the coartem(artemether/lumefantrine) market are Novartis, Sanofi-Aventis, KPC Pharmaceuticals, Inc, Guangxi Xiancaotang Pharmaceutical Co., LTD, Guilin Pharmaceutical Co., Ltd, Kerui Nanhai Pharmaceutical, Kunming Pharmaceutical, Novartis.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Coartem(Artemether/Lumefantrine) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Coartem(Artemether/Lumefantrine) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Coartem(Artemether/Lumefantrine) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Coartem(Artemether/Lumefantrine) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Coartem(Artemether/Lumefantrine) Market Size & Forecast, 2018-2028 4.5.1 Coartem(Artemether/Lumefantrine) Market Size and Y-o-Y Growth 4.5.2 Coartem(Artemether/Lumefantrine) Market Absolute $ Opportunity
Chapter 5 Global Coartem(Artemether/Lumefantrine) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Coartem(Artemether/Lumefantrine) Market Size Forecast by Type
5.2.1 Artemether
5.2.2 Lumefantrine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Coartem(Artemether/Lumefantrine) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Coartem(Artemether/Lumefantrine) Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Coartem(Artemether/Lumefantrine) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Coartem(Artemether/Lumefantrine) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Coartem(Artemether/Lumefantrine) Analysis and Forecast
9.1 Introduction
9.2 North America Coartem(Artemether/Lumefantrine) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Coartem(Artemether/Lumefantrine) Market Size Forecast by Type
9.6.1 Artemether
9.6.2 Lumefantrine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Coartem(Artemether/Lumefantrine) Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Online Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Coartem(Artemether/Lumefantrine) Analysis and Forecast
10.1 Introduction
10.2 Europe Coartem(Artemether/Lumefantrine) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Coartem(Artemether/Lumefantrine) Market Size Forecast by Type
10.6.1 Artemether
10.6.2 Lumefantrine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Coartem(Artemether/Lumefantrine) Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Online Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Coartem(Artemether/Lumefantrine) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Coartem(Artemether/Lumefantrine) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Coartem(Artemether/Lumefantrine) Market Size Forecast by Type
11.6.1 Artemether
11.6.2 Lumefantrine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Coartem(Artemether/Lumefantrine) Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Online Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Coartem(Artemether/Lumefantrine) Analysis and Forecast
12.1 Introduction
12.2 Latin America Coartem(Artemether/Lumefantrine) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Coartem(Artemether/Lumefantrine) Market Size Forecast by Type
12.6.1 Artemether
12.6.2 Lumefantrine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Coartem(Artemether/Lumefantrine) Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Online Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Coartem(Artemether/Lumefantrine) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Coartem(Artemether/Lumefantrine) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Coartem(Artemether/Lumefantrine) Market Size Forecast by Type
13.6.1 Artemether
13.6.2 Lumefantrine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Coartem(Artemether/Lumefantrine) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Online Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Coartem(Artemether/Lumefantrine) Market: Competitive Dashboard
14.2 Global Coartem(Artemether/Lumefantrine) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Sanofi-Aventis
14.3.3 KPC Pharmaceuticals, Inc
14.3.4 Guangxi Xiancaotang Pharmaceutical Co., LTD
14.3.5 Guilin Pharmaceutical Co., Ltd
14.3.6 Kerui Nanhai Pharmaceutical
14.3.7 Kunming Pharmaceutical
14.3.8 Novartis